Simran Farms (519566)
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹136.5 |
| Market Cap | ₹52.23 Cr |
| P/E Ratio | 0 |
| ROCE | 12.26% |
| ROE | -2.79% |
| Dividend Yield | 0% |
| Profit Growth | 707.14% |
| Debt/Equity | — |
| Sales Growth | -5.1% |
| 52-Week Range | ₹131.6 — ₹198 |
| Sector | Food Products |
| Book Value | ₹102.7 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Simran Farms is the kind of small, unproven operation that demands extra caution. A poultry and meat processor has no inherent moat; it is a commodity business competing on price and cost efficiency. The numbers reinforce my scepticism. Latest quarter sales of ₹233 Cr generated only ₹1 Cr net profit—a 0.4% margin. That is not a robust business; it is a razor-thin float. ROE is negative at -2.79%, so shareholder equity is earning nothing. Book value is ₹102.70, and the stock trades at ₹136.50, a 33% premium to book. For a business with negative return on equity, I do not want to pay a premium. ROCE is positive at 12.26%, suggesting operations cover capital costs before interest and taxes, but the shareholder bottom line remains weak. Sales declined 5.10%, showing no growth engine. The 707% profit growth looks exciting but comes off a base near zero—the latest quarterly net profit is just ₹1 Cr. Mr. Market has put the stock near its 52-week low, likely pricing in poor economics. The Piotroski score of 6/9 signals some improvement in financial health, but I refuse to pay for hope. There is no dividend, and missing debt and promoter holding data makes management quality and balance-sheet risk impossible to judge. In Graham's language, this is not a defensive stock. At best, it is a small speculative turnaround, and only if earnings stabilise and margins genuinely expand. The margin of safety is absent.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer